Epidemiology of Barrett's Esophagus: A Population Based Study
NCT01286155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 534
Last updated 2013-05-06
Summary
To assess attitudes toward screening for esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE) in the community.
To develop a population based clinical risk factor prediction model for the diagnosis of BE and identify novel risk factors for BE which would make population based screening more efficient. This will be an important first step in identifying the target population for BE screening, another crucial component of making screening feasible and efficient
Conditions
- Barrett's Esophagus
- Gastroesophageal Reflux Disease (GERD)
- Olmsted County Resident
Sponsors & Collaborators
-
American College of Gastroenterology
collaborator OTHER - lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
NCT05688176 ·Status: RECRUITING
-
The Microenvironment in Barrett's Esophagus
NCT03060642 ·Status: COMPLETED
-
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
NCT00844077 ·Status: COMPLETED
-
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT00288119 ·Status: RECRUITING
-
Racial Disparity in Barrett's Esophagus
NCT01374074 ·Status: COMPLETED
-
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
NCT02075905 ·Status: COMPLETED
-
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
NCT01124214 ·Status: COMPLETED ·Phase: NA
-
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
NCT05524844 ·Status: COMPLETED
-
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
NCT04295811 ·Status: UNKNOWN ·Phase: NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
NCT00574327 ·Status: RECRUITING
-
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
NCT04293458 ·Status: COMPLETED ·Phase: NA
-
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
NCT02464930 ·Status: UNKNOWN
-
University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository
NCT02427269 ·Status: ENROLLING_BY_INVITATION
-
The Effect of Ablation Therapy on Barrett's Esophagus
NCT00587314 ·Status: ENROLLING_BY_INVITATION
-
The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia
NCT04155242 ·Status: RECRUITING ·Phase: NA
-
Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma
NCT03216135 ·Status: UNKNOWN
-
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
NCT00431756 ·Status: ACTIVE_NOT_RECRUITING
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT03961945 ·Status: RECRUITING ·Phase: NA
-
Molecular Assessment for Gastro-Esophageal Cancer
NCT06346054 ·Status: RECRUITING ·Phase: NA
-
Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
NCT04316975 ·Status: COMPLETED ·Phase: NA
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
NCT01961778 ·Status: COMPLETED ·Phase: NA
-
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
NCT02560623 ·Status: COMPLETED ·Phase: NA
-
Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
NCT01568723 ·Status: COMPLETED
-
Obeticholic Acid for Prevention in Barrett's Esophagus
NCT04939051 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population
NCT05778851 ·Status: COMPLETED ·Phase: NA